companydata.dkcompanydata.dk

PHARMAZAN PHARMACEUTICALS ApS: Financial statements 2017

CVR: 32478697

Source: annual report 2017, Danish Business Authority

01/01/2017 – 31/12/2017

PHARMAZAN PHARMACEUTICALS ApS (CVR 32478697) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 494,031 and a net result of DKK 494,031 compared with DKK 354,557 the year before. That is an increase of 39.3% compared with the year before. Equity in the 2017 report amounted to DKK -77,977.

Gross Profit
DKK 494,031
Profit/Loss
DKK 494,031
Equity
DKK -77,977
Total Assets
DKK 740,874

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-494 t.494 t.-78 t.-
2016-355 t.355 t.-572 t.-
2015-96 t.92 t.-927 t.-
2014-280 t.807 t.-1 mio.-
2013--57 t.-89 t.-1.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on PHARMAZAN PHARMACEUTICALS ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

PHARMAZAN PHARMACEUTICALS ApS: The 2016 annual report is outMay 1, 2017

PHARMAZAN PHARMACEUTICALS ApS has published its annual report for 2016. Gross profit came to DKK 354,634, and the net result was DKK 354,557.

About PHARMAZAN PHARMACEUTICALS ApS

PHARMAZAN PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Frederikssund, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jens Otto Tram. The company is owned by HELSEFARMA ApS and TRAM HOLDING ApS. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK -21,837 and a net result of DKK -21,837 compared with DKK -40,416 the year before. Equity in the 2025 report amounted to DKK -64,051.

Source: annual report 2025, Danish Business Authority